Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

2008190 citationsJournal Article

Authors

Monthly oral ibandronate improves bone density and normalizes bone turnover in patients treated with anastrozole.

Good health and well-being

Published in: Clinical Cancer Research

Volume 14, Issue 19, pp. 6336-6342

Field-Weighted Citation Impact: 10.21